Cantargia AB (publ) (STO:CANTA)
3.885
+0.025 (0.65%)
Mar 23, 2026, 12:10 PM CET
Cantargia AB Employees
Cantargia AB had 22 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
22
Change
n/a
Growth
n/a
Revenue / Employee
14.40M SEK
Profits / Employee
6.68M SEK
Market Cap
959.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 22 | 0 | - |
| Sep 30, 2025 | 23 | 2 | 9.52% |
| Jun 30, 2025 | 23 | 0 | - |
| Mar 31, 2025 | 22 | -1 | -4.35% |
| Dec 31, 2024 | 22 | 0 | - |
| Sep 30, 2024 | 21 | -2 | -8.70% |
| Jun 30, 2024 | 23 | 0 | - |
| Mar 31, 2024 | 23 | -1 | -4.17% |
| Dec 31, 2023 | 22 | -4 | -15.38% |
| Sep 30, 2023 | 23 | -4 | -14.81% |
| Jun 30, 2023 | 23 | -4 | -14.81% |
| Mar 31, 2023 | 24 | -4 | -14.29% |
| Dec 31, 2022 | 26 | 0 | - |
| Sep 30, 2022 | 27 | 3 | 12.50% |
| Jun 30, 2022 | 27 | 4 | 17.39% |
| Mar 31, 2022 | 28 | 9 | 47.37% |
| Dec 31, 2021 | 26 | 8 | 44.44% |
| Sep 30, 2021 | 24 | 6 | 33.33% |
| Jun 30, 2021 | 23 | 8 | 53.33% |
| Mar 31, 2021 | 19 | 5 | 35.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioInvent International AB | 109 |
| Oncopeptides AB | 75 |
| Egetis Therapeutics AB | 42 |
| Diamyd Medical AB | 41 |
| Genovis AB (publ.) | 36 |
| Saniona AB | 34 |
| Xspray Pharma AB | 26 |
| Medivir AB | 10 |
Cantargia AB News
- 4 weeks ago - Cantargia AB (FRA:7V3) Q4 2025 Earnings Call Highlights: A Year of First-Time Profitability ... - GuruFocus
- 4 weeks ago - Q4 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 4 months ago - Cantargia AB (FRA:7V3) Q3 2025 Earnings Call Highlights: First-Ever Profits and Promising ... - GuruFocus
- 4 months ago - Q3 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 1 year ago - Cantargia AB (FRA:7V3) Q3 2024 Earnings Call Highlights: Strategic Shifts and Financial Updates - GuruFocus
- 1 year ago - Q3 2024 Cantargia AB Earnings Call Transcript - GuruFocus